Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 8278418 Modified animal erythropoietin polypeptides and their uses

Patent 8278418 was granted and assigned to Ambrx on October, 2012 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Ambrx

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

82784180

Patent Inventor Names

Feng Tian0

Anna-Maria A. Hays Putnam0

Darin Lee0

Peter C. Canning0

Richard S. Barnett0

Stephanie Chu0

Frank Song0

Joseph Sheffer0

...

Date of Patent

October 2, 2012

Patent Application Number

125676270

Date Filed

September 25, 2009

Patent Citations Received

‌

US Patent 11786578 Modified relaxin polypeptides and their uses

‌

US Patent 12060148 Ground resonance detection and warning system and method

Patent Primary Examiner

‌

Christine J. Saoud

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8278418 Modified animal erythropoietin polypeptides and their uses

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API